ERIM
SNY icon

Eagle Ridge Investment Management’s Sanofi SNY Stock Holding History

Eagle Ridge Investment Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$273K Buy
5,656
+85
+2% +$4.32K 0.02% 128
2024
Q3 		$321K Buy
5,571
+203
+4% +$11K 0.03% 120
2024
Q2 		$260K Hold
5,368
– – 0.02% 126
2024
Q1 		$261K Sell
5,368
-26,977
-83% -$1.32M 0.02% 132
2023
Q4 		$1.61M Sell
32,345
-170,900
-84% -$8.36M 0.16% 61
2023
Q3 		$10.9M Sell
203,245
-32
-0% -$1.71K 1.19% 31
2023
Q2 		$11M Sell
203,277
-978
-0.5% -$52.6K 1.15% 35
2023
Q1 		$11.1M Sell
204,255
-144,555
-41% -$7.03M 1.25% 33
2022
Q4 		$16.9M Buy
348,810
+3,229
+0.9% +$142K 1.97% 11
2022
Q3 		$13.1M Buy
345,581
+3,637
+1% +$162K 1.65% 14
2022
Q2 		$17.1M Buy
341,944
+215
+0.1% +$11.4K 2.06% 10
2022
Q1 		$17.5M Buy
341,729
+9,271
+3% +$479K 1.87% 14
2021
Q4 		$16.7M Sell
332,458
-803
-0.2% -$39.7K 1.74% 17
2021
Q3 		$16.1M Buy
333,261
+6,731
+2% +$342K 1.79% 14
2021
Q2 		$17.2M Sell
326,530
-1,587
-0.5% -$82.8K 1.99% 13
2021
Q1 		$16.2M Buy
328,117
+170,681
+108% +$8.2M 1.96% 11
2020
Q4 		$7.65M Buy
+157,436
New +$7.76M 0.97% 46
2018
Q4 		– Sell
-7,570
Closed -$338K – 172
2018
Q3 		$338K Hold
7,570
– – 0.05% 129
2018
Q2 		$303K Hold
7,570
– – 0.05% 136
2018
Q1 		$303K Sell
7,570
-3,200
-30% -$133K 0.05% 137
2017
Q4 		$463K Hold
10,770
– – 0.07% 116
2017
Q3 		$536K Sell
10,770
-350
-3% -$16.9K 0.09% 104
2017
Q2 		$160K Buy
+11,120
New +$531K 0.03% 132
2017
Q1 		– Sell
-5,725
Closed -$232K – 146
2016
Q4 		$232K Buy
+5,725
New +$226K 0.05% 128

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eagle Ridge Investment Management's SNY Position: Q4 2024 in Review

Eagle Ridge Investment Management increased its Sanofi (SNY) stake by 1.5% in Q4 2024, buying an estimated $4.32K and bringing the position to 5,656 shares worth $273K. The position accounts for 0.02% of the portfolio, ranked #128.

Eagle Ridge Investment Management first reported a position in SNY in Q4 2016 and has held it in 24 quarters since. The position peaked at $17.5M in Q1 2022. 730 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

  • Eagle Ridge Investment Management held 5,656 shares of Sanofi worth $273K as of Q4 2024.
  • Eagle Ridge Investment Management bought 85 Sanofi shares in Q4 2024, an estimated $4.32K.
  • Sanofi made up 0.02% of Eagle Ridge Investment Management's portfolio in Q4 2024, its #128 holding.
  • Eagle Ridge Investment Management first reported a position in Sanofi in Q4 2016 and has held it in 24 quarters since.
  • Eagle Ridge Investment Management's Sanofi position peaked at $17.5M in Q1 2022.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on Eagle Ridge Investment Management's 13F filing for Q4 2024, filed 27 Jan 2025.